Audrey Lasek
Overview
Explore the profile of Audrey Lasek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
124
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Barbarot S, Aubert H, Vibet M, Leray M, Foureau A, Elan F, et al.
Br J Dermatol
. 2024 Jun;
191(2):177-186.
PMID: 38863109
Background: Therapeutic patient education (TPE) is recommended for children with atopic dermatitis (AD), but no consensus has been reached on the optimal tailoring of delivery. While repeated multidisciplinary group education...
2.
Hanafi B, Beauchet A, Di Lernia V, Lasek A, Severino-Freire M, Barbarot S, et al.
Pediatr Dermatol
. 2023 Jul;
40(5):835-840.
PMID: 37442765
Background: Palmoplantar plaque psoriasis is a frequent clinical subtype of childhood psoriasis. This study evaluated the effectiveness of biologic therapies in children with palmoplantar plaque psoriasis using data from the...
3.
Vanlerberghe J, Dezoteux F, Martin C, Jachiet M, Soria A, Tetart F, et al.
J Am Acad Dermatol
. 2022 Oct;
88(4):900-904.
PMID: 36280001
No abstract available.
4.
Zitouni J, Beauchet A, Curmin R, Di Lernia V, Bursztejn A, Mazereeuw-Hautier J, et al.
Paediatr Drugs
. 2022 Apr;
24(3):281-292.
PMID: 35397731
Introduction: Biological therapies are valuable treatments for severe psoriasis. Children aged under 12 years are underrepresented in therapeutic trials for these drugs. The objective of the 'BiPe Jr' cohort study...
5.
Phan C, Beauchet A, Reguiai Z, Severino-Freire M, Mazereeuw-Hautier J, Bursztejn A, et al.
Pediatr Dermatol
. 2021 Dec;
39(1):35-41.
PMID: 34888920
Background: There is currently little information on switching biologics in pediatric psoriasis. Objective: To evaluate the real-world clinical practice and safety of switching biologics in the "Biological Treatments for Pediatric...
6.
Ahangari D, Gillard M, Certad G, Bataille M, Lasek A, Modiano P
JAAD Case Rep
. 2019 Sep;
5(9):831-833.
PMID: 31517009
No abstract available.
7.
Maudinet A, Law-Koune S, Duretz C, Lasek A, Modiano P, Tran T
Ophthalmol Ther
. 2019 Jun;
8(3):485-490.
PMID: 31230264
We report 10 cases of conjunctivitis in atopic dermatitis (AD) patients treated with dupilumab from November 2017 to November 2018 in our institution, who were referred to the ophthalmology department...
8.
Phan C, Beauchet A, Burztejn A, Severino-Freire M, Mazereeuw-Hautier J, Barbarot S, et al.
Paediatr Drugs
. 2019 Jun;
21(3):169-175.
PMID: 31155692
Background: Phase III clinical trials of biotherapies for childhood psoriasis are designed for a selected population, which can differ from real-life patients. Objective: Our objective was to assess the proportion...
9.
Faiz S, Giovannelli J, Podevin C, Jachiet M, Bouaziz J, Reguiai Z, et al.
J Am Acad Dermatol
. 2019 Mar;
81(1):143-151.
PMID: 30825533
Background: Dupilumab is the first biologic available to treat atopic dermatitis (AD). Its effectiveness and safety were demonstrated in clinical trials. Objective: We sought to assess the effectiveness and safety...
10.
Lamiaux M, Dabouz F, Wantz M, Lebas D, Lasek A, Courivaud D, et al.
JAAD Case Rep
. 2018 Jan;
4(1):17-21.
PMID: 29296643
No abstract available.